Previous close | 0.2000 |
Open | 0.3500 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 10.00 |
Expiry date | 2024-05-17 |
Day's range | 0.2000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 71 |
CAMBRIDGE, Mass., May 14, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
Exploring the Financial Landscape and Strategic Progress Amidst Challenges
CAMBRIDGE, Mass., May 07, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2024.